Before evaluating the in vivo anti-cancer effects of TMQ0153, the toxicity of various doses of the compound was assessed in key organs, including the heart, spleen, lungs, liver, and kidneys
doi: 10.1002/advs.202002928 131 ThackerVVSharmaKDharNManciniGSordet-DessimozJMcKinneyJD
Compounded medications, research-only peptides, foreign-purchased products, unlabeled syringes, and powders can raise different screening, customs, pharmacy, or legal issues
The See more button is for visual users only to expose content incrementally that is already available to you
Google Scholar DAlessandro A, Fu X, Reisz JA
10.1021/acs.jafc.2c07005 82 LucasS.OmataY.HofmannJ.BttcherM.IljazovicA.SarterK.et al (2018)